Chu Yu-Waye 4
4 · FATE THERAPEUTICS INC · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Chu Yu-Waye
Senior VP Clinical Development
Transactions
- Sale
Common Stock
2023-04-18$6.52/sh−215$1,402→ 142,993 total - Sale
Common Stock
2023-04-18$6.58/sh−2,317$15,246→ 140,676 total
Footnotes (3)
- [F1]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 7,500 shares of Common Stock underlying RSUs granted to the Reporting Person on April 15, 2019. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold from $6.46 to $6.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2-3.
- [F3]Represents the weighted average sale price of the shares sold from $6.56 to $6.60 per share.